Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in Journal of Ophthalmology
- Vol. 2015, 1-11
Abstract
Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (STZ) treatment or Insulin2 gene mutation (Akita) in mice. Protein expression and localization were examined by western blots (WB) and immunofluorescence (IF). mRNA expression was quantified by PCR array and real-time PCR. The activity of VEGFR1 signaling was blocked by a neutralizing antibody called MF1. Vascular leakage was evaluated by measuring the leakage of [3H]-mannitol tracer into the retina and the IF staining of albumin. VEGFR1 blockade significantly inhibited diabetes-related vascular leakage, leukocytes-endothelial cell (EC) adhesion (or retinal leukostasis), expression of intercellular adhesion molecule- (ICAM-) 1 protein, abnormal localization and degeneration of the tight junction protein zonula occludens- (ZO-) 1, and the cell adhesion protein vascular endothelial (VE) cadherin. In addition, VEGFR1 blockade interfered with the gene expression of 10 new cytokines and chemokines: cxcl10, il10, ccl8, il1f6, cxcl15, ccl4, il13, ccl6, casp1, and ccr5. These results suggest that VEGFR1 mediates complications of DR and targeting this signaling pathway represents a potential therapeutic strategy for the prevention and treatment of DR.Keywords
Funding Information
- Janssen Research and Development (013GSF31804)
- BrightFocus Foundation (013GSF31804)
- Science and Technology Development Plan of Shandong Province (013GSF31804)
- Wilmer Pooled Professor Funds (013GSF31804)
This publication has 37 references indexed in Scilit:
- VEGF Receptor Blockade Markedly Reduces Retinal Microglia/Macrophage Infiltration into Laser-Induced CNVPLOS ONE, 2013
- Targeted deletion of Vegfa in adult mice induces vision lossJournal of Clinical Investigation, 2012
- Reduced Retinal Neovascularization, Vascular Permeability, and Apoptosis in Ischemic Retinopathy in the Absence of Prolyl Hydroxylase-1 Due to the Prevention of Hyperoxia-Induced Vascular ObliterationInvestigative Ophthalmology & Visual Science, 2011
- Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the EyePLOS ONE, 2011
- TNFα Is Required for Late BRB Breakdown in Diabetic Retinopathy, and Its Inhibition Prevents Leukostasis and Protects Vessels and Neurons from ApoptosisInvestigative Ophthalmology & Visual Science, 2011
- Temporal requirement of RPE‐derived VEGF in the development of choroidal vasculatureJournal of Neurochemistry, 2010
- Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathyNature Medicine, 2009
- Accuracy and precision in quantitative fluorescence microscopyJournal of Cell Biology, 2009
- FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?Nature Reviews Cancer, 2008
- Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and PhotoreceptorsPLOS ONE, 2008